Advertisement

Topics

Lichtwer Healthcare GmbH & Co. KG Company Profile

11:48 EDT 18th June 2018 | BioPortfolio

Lichtwer is one of the leading manufacturers of highly effective herbal remedies and health promoting products. The company develops and produces - for clients (toll manufacturing), too - innovative preparations of high value. As a pioneer of self medication - national as well as international - we combine our vast experience in therapy with the results of the many years of medical research and development

Location

Wallenroder Str. 8-10
Berlin
D - 13435
Germany

Contact

Phone: 49 (30)-40 37 0-0
Fax: 49 (30)-40 37 0-103
Email: info@lichtwer.de


News Articles [733 Associated News Articles listed on BioPortfolio]

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

BIOCRATES Life Sciences AG Acquires Metanomics Health GmbH

BIOCRATES Life Sciences AG announced the acquisition of Metanomics Health GmbH. Metanomics Health is a metabolomics biomarker development and healthcare services specialist based in Berlin, Germany. A...

DGAP-News: STADA Arzneimittel AG: Hauptversammlung stimmt Beherrschungs- und Gewinnabführungsvertrag mit der Nidda Healthcare GmbH zu (deutsch)

STADA Arzneimittel AG: Hauptversammlung stimmt Beherrschungs- und Gewinnabführungsvertrag mit der Nidda Healthcare GmbH zu DGAP-News: STADA Arzneimittel AG / Schlagwort(e): Sonstiges STADA Arzneim...

Randox and Bosch Partner to Launch Molecular Diagnostics Platform

Global healthcare diagnostics manufacturer Randox Laboratories has partnered with Bosch Healthcare Solutions GmbH to launch Vivalytic, an all-in-one fully automated...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

DGAP-Adhoc: STADA Arzneimittel AG: 19. Dezember 2017, 17:15Uhr; Beherrschungs- und Gewinnabführungsvertrag gemäß §§ 291 ff. AktG zwischen STADA Arzneimittel AG und Nidda Healthcare GmbH abgeschlossen (deutsch)

STADA Arzneimittel AG: 19. Dezember 2017, 17:15Uhr; Beherrschungs- und Gewinnabführungsvertrag gemäß §§ 291 ff. AktG zwischen STADA Arzneimittel AG und Nidda Healthcare GmbH abgeschlossen DGAP-Ad...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

STADA Arzneimittel AG: Beherrschungs- und Gewinnabführungsvertrag erlangt Wirksamkeit

Bad Marienberg - Der Beherrschungs- und Gewinnabführungsvertrag (BGAV) zwischen der Nidda Healthcare GmbH (Nidda Healthcare) als herrschender Gesellschaft und der STADA Arzneimittel AG (ISIN DE0007.....

PubMed Articles [1038 Associated PubMed Articles listed on BioPortfolio]

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

A Future-Focused Approach to Behavioral Healthcare.

Interview With Rulon F. Stacey, PhD, FACHE, Managing Director, Healthcare, Navigant Consulting.

Practitioner Application: Ten CEO Imperatives for Healthcare Transformation: Lessons From Top-Performing Academic Medical Centers.

Healthcare use for children with complex needs: using routine health data linked to a multiethnic, ongoing birth cohort.

Congenital anomaly (CA) are a leading cause of disease, death and disability for children throughout the world. Many have complex and varying healthcare needs which are not well understood. Our aim wa...

Clinical Trials [1029 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Companies [2317 Associated Companies listed on BioPortfolio]

Lichtwer Healthcare GmbH & Co. KG

Lichtwer is one of the leading manufacturers of highly effective herbal remedies and health promoting products. The company develops and produces - for clients (toll manufacturing), too - innovative p...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Lichtwer Healthcare GmbH & Co. KG" on BioPortfolio

We have published hundreds of Lichtwer Healthcare GmbH & Co. KG news stories on BioPortfolio along with dozens of Lichtwer Healthcare GmbH & Co. KG Clinical Trials and PubMed Articles about Lichtwer Healthcare GmbH & Co. KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lichtwer Healthcare GmbH & Co. KG Companies in our database. You can also find out about relevant Lichtwer Healthcare GmbH & Co. KG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record